All In Biotech

Drug Trial Radar · NCT06401044

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects With Moderate-to-Severe Active Thyroid Eye Disease

Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

94

Actual

Start

May 30, 2024

Primary completion

Jan 6, 2027

Study completion Dec 24, 2027

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
May 6, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of Part A of this study is to investigate the safety and tolerability of AMG 732 after single subcutaneous (SC) doses. The primary objective of Part B of this study is to investigate the efficacy of AMG 732 in participants with Thyroid Eye Disease (TED) after multiple SC doses.

Conditions

  • Thyroid Eye Disease

Interventions

  • AMG 732Drug

    SC injection

  • PlaceboOther

    SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Number of Participants With Treatment-emergent Adverse EventsTime frame: Day 1 through Week 36 (End of Study)
  2. Part B: Change from Baseline in Proptosis Measurement by an Exophthalmometer in the Study EyeTime frame: Baseline to End of Treatment (EoT) (approximately 6 Months)

Locations

44 sites in 12 countries. Site status is shown where the registry gives one.

  • Applied Research Center of Arkansas

    Little Rock, Arkansas

  • Amy Patel Jain MD

    Newport Beach, California

  • Levenson Eye Associates

    Jacksonville, Florida

  • Ilumina Medical Research

    Kissimmee, Florida

  • Sarasota Retina Institute

    Sarasota, Florida

  • Vision Medical Research, Inc.

    Orland Park, Illinois

  • Massachusetts Eye and Ear Infirmary

    Boston, Massachusetts

  • Ppd Las Vegas Research Unit

    Las Vegas, Nevada

  • Erie Retina Research

    Erie, Pennsylvania

  • Baylor College of Medicine Medical Center

    Houston, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • West Virginia University

    Morgantown, West Virginia

  • Macquarie University

    North Ryde, New South Wales, Australia

  • North Shore Private Hospital

    St Leonards, New South Wales, Australia

  • Vancouver General Hospital

    Vancouver, British Columbia, Canada

  • Santé Québec Est-de-l'Île-de-Montréal - Universitaire

    Montreal, Quebec, Canada

  • CHU de Québec-Université Laval - CUO-Recherche Clinique, Hopital du Saint-Sacrement

    Québec, Quebec, Canada

  • Centre Hospitalier Universitaire de Nantes - Hopital Nord Laennec

    Nantes, France

  • Hopital Pitie-Salpetriere

    Paris, France

  • Universitaetsklinikum Essen

    Essen, Germany

  • Buergerhospital und Clementine Kinderhospital gGmbH

    Frankfurt am Main, Germany

  • Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Germany

  • Universitaetsklinikum Leipzig AoeR

    Leipzig, Germany

  • General Hospital of Athens Laiko

    Athens, Greece

  • Ippokratio General Hospital of Thessaloniki

    Thessaloniki, Greece

  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • Azienda Ospedaliero Universitaria Pisana

    Pisa, Italy

  • Azienda Ospedaliero Universitaria Pisana

    Pisa, Italy

  • Azienda Socio Sanitaria Territoriale dei Sette Laghi

    Varese, Italy

  • Aichi Medical University Hospital

    Nagakute-shi, Aichi-ken, Japan

  • Hayashi Eye Hospital

    Fukuoka, Fukuoka, Japan

  • Kozawa Eye Hospital And Diabetes Center

    Mito, Ibaraki, Japan

  • University of Miyazaki Hospital

    Miyazaki, Miyazaki, Japan

  • Profesorskie Centrum Medyczne Spolka z Ograniczona Odpowiedzialnoscia

    Gdansk, Poland

  • Uniwersyteckie Centrum Stomatologii I Medycyny Specjalistycznej Spzoo

    Poznan, Poland

  • Dc-Med Spolka z Ograniczona Odpowiedzialnoscia Spolka Komandytowa

    Swidnica, Poland

  • Eb Group Spolka z ograniczona odpowiedzialnoscia

    Warsaw, Poland

  • National University Hospital

    Singapore, Singapore

  • Singapore National Eye Centre

    Singapore, Singapore

  • Hospital Universitario Ramon y Cajal

    Madrid, Spain

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.